A Jaundiced Child
A jaundiced child presents with yellow discoloration of the skin and sclera due to elevated bilirubin, requiring systematic evaluation to distinguish physiological, hemolytic, hepatocellular, or obstructive causes across different age groups.
A Jaundiced Child — Comprehensive Exam-Ready Notes
This lecture (GC 146) is delivered jointly by Paediatrics (Dr YY Chee) and Paediatric Surgery (Dr KKY Wong). It is a core neonatology topic that covers the full spectrum of neonatal jaundice (NNJ) — from the benign physiological variant through to life-threatening conjugated hyperbilirubinemia requiring surgical intervention. The lecture is structured around understanding why neonates become jaundiced (physiology), recognising when it becomes dangerous (kernicterus), and knowing what to do (clinical approach, phototherapy, exchange transfusion, Kasai operation, liver transplant). [1]
How this fits into exams: NNJ is one of the most commonly tested paediatric topics in HKUMed summative papers. Expect MCQs on distinguishing physiological vs pathological jaundice, identifying conjugated hyperbilirubinemia as the red flag for biliary atresia, the mechanism of phototherapy, risk factors for kernicterus, and the timing of Kasai portoenterostomy. Past paper questions (2023, 2025) have directly tested this content. [2][3]
Learning Objectives (from slide 3)
1. Physiology of NNJ 2. Other pathological causes of NNJ 3. NNJ hazard – KERNICTERUS 4. Conjugated hyperbilirubinemia 5. Clinical Approach to NNJ 6. Breastmilk jaundice [1]
Jaundice results from bilirubin accumulation in skin and sclera
- Yellow → unconjugated bilirubin
- Yellow with green hue → conjugated bilirubin In neonates, jaundice is visible when it reaches 80–100 µmol/L (4.5–6.0 mg/dL) [1]
Why is the threshold lower than in adults? Neonatal skin is thinner and has less melanin, making bilirubin deposition more visible at lower levels. In adults, jaundice is typically visible at ~50 µmol/L in the sclera, but because neonates have a different subcutaneous fat distribution and skin characteristics, 80–100 µmol/L is the clinical detection threshold.
Kramer's Rule (from senior notes): Jaundice progresses in a cephalocaudal direction — face first (≈85 µmol/L), then trunk, then to the soles (≈342 µmol/L). This is clinically useful but unreliable for precise measurement, which is why we use transcutaneous bilirubinometry or serum bilirubin. [4]
The colour distinction matters clinically:
- Pure yellow = unconjugated = usually benign physiological/breastmilk jaundice (but watch for dangerously high levels)
- Yellow-green = conjugated = always pathological → think biliary atresia, neonatal hepatitis, metabolic disease
Over 50% of term infants and 80% of preterm infants will have clinical jaundice within the first few days of life More common in Asian population [1]
Why is it so common? Because every single neonate has all three physiological reasons (high haemoglobin load, immature liver, enterohepatic circulation) working against them. The Asian predisposition is partly due to a higher frequency of UGT1A1 gene polymorphisms (the same gene responsible for Gilbert syndrome) and possibly G6PD deficiency prevalence in certain Asian populations.
3. Physiology of Neonatal Jaundice — From First Principles
This is the conceptual backbone of the entire lecture. Understand these three mechanisms and everything else falls into place.
Bilirubin is the breakdown product of haem [1]
Haem (from RBC breakdown in reticuloendothelial system)
↓ Heme oxygenase
Biliverdin + CO
↓ Biliverdin reductase
Unconjugated bilirubin (HYDROPHOBIC)
↓ Binds albumin for transport
Liver (uptake by ligandin → conjugation by UDPGT)
↓
Conjugated bilirubin = bilirubin diglucuronide (HYDROPHILIC)
↓ Excreted into bile → gut
Gut bacteria convert to urobilinogen
↓
80-90% excreted: stercobilin (stool), urobilin (urine)
10-20% reabsorbed → enterohepatic circulationUnconjugated bilirubin is hydrophobic → binds to albumin and is transported to the liver [1]
Why does this matter? Because unconjugated bilirubin is hydrophobic, it can cross lipid membranes including the blood-brain barrier (BBB). This is the fundamental reason kernicterus occurs. Conjugated bilirubin is water-soluble and cannot cross the BBB — hence conjugated hyperbilirubinemia does NOT cause kernicterus (but reflects serious hepatobiliary disease).
1. UPSTREAM: High Hb load in neonates (mean 17–19 g/dL) + Short RBC lifespan (half-life 80 days) [1]
Why? Fetal haemoglobin (HbF) has a higher oxygen affinity than adult HbA — this is necessary in utero to "steal" oxygen from maternal blood across the placenta. After birth, the neonate no longer needs HbF, so there is a massive wave of RBC destruction to replace HbF with HbA. This releases enormous quantities of haem. Additionally, neonatal RBCs have a shorter lifespan (~90 days vs ~120 days for adult RBCs), further increasing haem turnover.
2. DOWNSTREAM: Immature liver metabolic function
- Low ligandin (uptake of bilirubin into liver cells)
- Low conjugation enzyme activity (UDPGT) [1]
Why? The neonatal liver simply hasn't matured yet. Ligandin (also known as glutathione S-transferase B) is the intracellular protein that "grabs" unconjugated bilirubin from albumin once it arrives at the hepatocyte. Low ligandin = poor uptake. UDPGT (uridine diphosphoglucuronosyltransferase, also written as UGT1A1) is the enzyme that conjugates bilirubin with glucuronic acid, making it water-soluble. This enzyme only reaches adult activity levels by about 2 weeks of age.
3. ENTEROHEPATIC CIRCULATION — "recycling" of bilirubin from gut to blood, especially when feeding is minimal in the first 2–3 days of life [1]
Why? In the neonatal gut:
- The gut is relatively sterile (no gut flora to convert bilirubin to urobilinogen for excretion)
- β-glucuronidase in the intestinal brush border deconjugates bilirubin diglucuronide back to unconjugated bilirubin
- This unconjugated bilirubin is reabsorbed into the portal circulation → sent back to the liver
- When feeding is minimal (first 2–3 days), intestinal transit is slow → more time for reabsorption
UDPGT genetic variation (polymorphism) common — affects activity
- Common: Gilbert syndrome
- Uncommon: Crigler-Najjar syndrome [1]
| Condition | UDPGT Activity | Inheritance | Clinical Significance |
|---|---|---|---|
| Gilbert syndrome | ~30% of normal | AD (variable penetrance) | Mild unconjugated hyperbilirubinemia, benign, worsens with fasting/stress; very common (~5–10% of population) |
| Crigler-Najjar Type I | Absent | AR | Severe unconjugated hyperbilirubinemia from birth, kernicterus risk, requires lifelong phototherapy ± liver transplant |
| Crigler-Najjar Type II | Very low (~10%) | AR | Moderate severity, responds partially to phenobarbital (induces residual enzyme activity) |
"Physiologic" jaundice:
- Apparent from day 2–3 of life
- Peak at day 4–5
- Subside by day 7–14 Laboratory tests:
- Unconjugated hyperbilirubinemia (commonly > 170 µmol/L)
- Normal hepatic ductal and parenchymal enzymes
- Absent conjugated fraction
- Blood smear: no evidence of haemolysis [1]
High Yield — Physiological Jaundice Definition
Physiological NNJ = unconjugated hyperbilirubinemia appearing Day 2–3, peaking Day 4–5, resolving by Day 7–14, with normal liver enzymes, no conjugated fraction, and no haemolysis on blood smear. Anything outside this pattern is pathological until proven otherwise.
The type of hyperbilirubinemia in physiological NNJ is UNCONJUGATED bilirubin. [1]
Causes of severe NNJ (unconjugated hyperbilirubinemia):
- Haemolysis
- Immune causes: e.g. Rhesus incompatibility, ABO incompatibility
- Non-immune: e.g. G6PD deficiency
- Extravasation of blood: e.g. cephalhematoma, intraventricular haemorrhage
- Polycythaemia
- Inadequate feeding
- Sepsis [1]
Differential Diagnosis of NNJ by Timing
| Timing | Causes |
|---|---|
| Early ( < 24 hours) | Haemolytic disorders: ABO/Rh incompatibility, G6PD deficiency, hereditary spherocytosis, thalassaemia; Congenital infection |
| Normal (24h–2 weeks) | Physiological jaundice, breastmilk/breastfeeding jaundice, infection (esp UTI), haemolysis, cephalhematoma, polycythaemia, Crigler-Najjar |
| Prolonged ( > 2 weeks term, > 3 weeks preterm) — Unconjugated: physiological, breastmilk jaundice, infection, hypothyroidism, haemolysis, high GI obstruction (e.g. pyloric stenosis) | |
| Prolonged — Conjugated: Biliary atresia, choledochal cyst, neonatal hepatitis, metabolic disease (galactosemia, citrin deficiency), α1-antitrypsin deficiency, CF, Alagille syndrome |
Exam Trap
Jaundice in the first 24 hours of life is NEVER physiological — always pathological (usually haemolytic). This is an extremely common exam discriminator. If the stem says "jaundice from birth" or "jaundice at 12 hours of age," think haemolysis first.
6. Kernicterus — The Hazard of NNJ
Unconjugated bilirubin is hydrophobic → can cross lipid layers and blood-brain barrier → causes damage to neural tissue Most unconjugated bilirubin is bound to albumin (protective) Risk is higher when "free" bilirubin is high:
- When albumin is low
- When there is competitive binding to albumin, e.g. drugs [1]
"Free" unconjugated bilirubin (i.e. NOT bound to albumin) is the neurotoxic fraction. It preferentially deposits in the basal ganglia (globus pallidus, subthalamic nuclei), brainstem auditory nuclei, and oculomotor nuclei — explaining the triad of clinical features.
Risks of kernicterus higher when:
- Very high unconjugated bilirubin level in blood for a prolonged period
- High "free" bilirubin
- Haemolysis
- Sepsis
- Acidosis
- Hypoglycaemia
- Prematurity [1]
Why each factor increases risk:
- Haemolysis: produces bilirubin faster than the liver can clear it, leading to very high levels
- Sepsis: opens the BBB (inflammation increases permeability), impairs hepatic function
- Acidosis: unconjugated bilirubin binds albumin less tightly at low pH → more free bilirubin
- Hypoglycaemia: brain already metabolically stressed → more susceptible to bilirubin toxicity
- Prematurity: lower albumin levels, more immature BBB, less mature hepatic conjugation
Early: hypotonia, poor feeding, lethargy, hypertonia, opisthotonus, fever, convulsion, death Late: extrapyramidal signs (dystonic cerebral palsy), hearing loss (SNHL), upward gaze palsy [1]
| Phase | Clinical Features | Notes |
|---|---|---|
| Acute bilirubin encephalopathy (early/reversible) | Hypotonia → hypertonia, poor feeding, lethargy, high-pitched cry, opisthotonus, seizures, fever, death | If caught early and bilirubin reduced, may be reversible |
| Kernicterus (chronic/irreversible) | Dystonic cerebral palsy, sensorineural hearing loss, upward gaze palsy, intellectual disability, dental enamel dysplasia | Permanent neurological damage; "kern" = nucleus (basal ganglia staining) |
Why Hearing Loss and Upward Gaze Palsy?
Bilirubin has tropism for the cochlear nuclei and inferior colliculi (brainstem auditory pathway) → sensorineural hearing loss. It also deposits in the oculomotor nuclei/superior colliculi → upward gaze palsy. The basal ganglia damage causes the extrapyramidal/dystonic cerebral palsy. These three features together are essentially pathognomonic of kernicterus.
7. Clinical Approach to Neonatal Jaundice
History:
- Gestation, prenatal complications
- Birth weight
- Age of life
- Feeding details
- Blood groups / G6PD status
- Other postnatal complications e.g. infection [1]
Why each matters:
- Gestation: preterm infants are at higher risk (immature liver, lower albumin, more permeable BBB)
- Birth weight: low birth weight correlates with prematurity and smaller albumin reserves
- Age of life: timing of jaundice onset is the single most important discriminator (< 24h = always pathological)
- Feeding details: breastfeeding vs formula, adequacy of intake → breastfeeding/breastmilk jaundice
- Blood groups/G6PD: mother-baby Rh/ABO incompatibility? G6PD deficiency screen (mandatory in HK newborn screening)
- Infection: sepsis worsens jaundice and increases kernicterus risk
Physical examination:
- Severity of jaundice – using transcutaneous bilirubinometer
- Hydration
- Pallor / plethora
- Cephalhematoma / bruises
- Neurologic state
- Size of liver and spleen [1]
Why each matters:
- Transcutaneous bilirubinometer: non-invasive screening; if above threshold → confirm with serum bilirubin
- Hydration: dehydration concentrates bilirubin and suggests inadequate feeding
- Pallor: suggests haemolysis (anaemia from RBC destruction)
- Plethora: suggests polycythaemia (more RBCs → more haem breakdown)
- Cephalhematoma/bruises: extravasated blood = extra source of haem for breakdown
- Neurologic state: looking for signs of acute bilirubin encephalopathy (lethargy, hypotonia/hypertonia, opisthotonus)
- Hepatosplenomegaly: may suggest haemolysis (extramedullary haematopoiesis), infection, or hepatobiliary disease
Lab test: TOTAL SERUM BILIRUBIN [1]
The key initial test. But you must also request fractionated bilirubin (direct/conjugated vs indirect/unconjugated) to determine whether this is unconjugated or conjugated hyperbilirubinemia — this distinction is critical for the entire diagnostic pathway.
Additional investigations depending on clinical picture:
- CBC + reticulocyte count + blood smear (haemolysis?)
- Blood grouping of mother and baby (ABO/Rh incompatibility?)
- Direct Coombs test (immune haemolysis?)
- G6PD assay
- LFT including conjugated bilirubin, ALT, AST, ALP, GGT, albumin
- Infection screen if sepsis suspected
- Thyroid function tests if jaundice prolonged
8. Treatment of Neonatal Jaundice
Treatment — Phototherapy:
- Photo-isomerisation of bilirubin to less toxic (hydrophilic) and readily excretable forms (in bile and urine)
- Wavelength 460 nm (BLUE light spectrum) Mild side effects:
- Corneal or retinal damage (use eye shield)
- Dehydration
- Skin rash
- Loose stool [1]
Mechanism explained from first principles:
Unconjugated bilirubin is a tetrapyrrole with a specific stereochemistry (4Z,15Z configuration). When blue light (peak ~460 nm) hits the bilirubin molecules deposited in the skin:
- Structural isomerisation → converts to lumirubin, which is water-soluble and can be excreted in bile and urine WITHOUT conjugation
- Configurational isomerisation → converts from the 4Z,15Z form to the 4Z,15E form, which is also more water-soluble
This is why phototherapy works without the liver needing to do anything — it bypasses the conjugation bottleneck entirely.
Side effects explained:
- Eye damage: intense blue light can harm the immature retina → always use eye shields
- Dehydration: insensible water loss increases because the baby is undressed under lights → monitor weight and fluid intake
- Skin rash & loose stool: direct effects of photoisomers being excreted
Intervene before plasma bilirubin reaches "risky" level:
- Term: < 20 mg/dL (340 µmol/L)
- Lower in preterm infants "Free" bilirubin is not readily measurable [1]
In practice, nomograms (e.g. Bhutani nomogram/AAP guidelines) plot total serum bilirubin against hours of age and risk zone to determine when to initiate phototherapy. The lecture gives the general principle: don't let term babies exceed ~340 µmol/L, and use lower thresholds for preterm infants (who have less albumin and more permeable BBB).
Exchange Transfusion:
- Rapid way to remove plasma bilirubin by gradual exchange of patient's blood
- Indicated when plasma bilirubin reaches a dangerous level (e.g. > 380 µmol/L) or child already showing signs of neurotoxicity [1]
Mechanism: Double-volume exchange transfusion removes approximately 85% of the baby's circulating RBCs and ~50% of the extravascular bilirubin. It simultaneously provides fresh albumin with binding capacity for remaining bilirubin. In immune haemolysis (Rh disease), it also removes the offending maternal antibodies and the antibody-coated neonatal RBCs.
Risks: Cardiac arrhythmia (from electrolyte shifts, especially calcium and potassium), infection, air embolism, thrombocytopenia, necrotizing enterocolitis (NEC). This is why it's reserved for dangerous bilirubin levels or when phototherapy fails.
IVIg for immune haemolytic jaundice [1]
Why? In immune-mediated haemolysis (Rh or ABO incompatibility), maternal IgG antibodies are destroying neonatal RBCs. IVIg works by competitively blocking Fc receptors on reticuloendothelial cells, thereby reducing the rate of antibody-mediated RBC destruction. It can reduce the need for exchange transfusion.
This is a classic exam discriminator. The lecture explicitly distinguishes these two entities:
Breast milk supply may be inadequate during first few days of life: decrease bilirubin excretion
- Increase enterohepatic circulation → reabsorption of unconjugated bilirubin (by intestinal β-glucuronidase deconjugation) into blood
- THIS IS REFERRED TO AS BREASTFEEDING JAUNDICE (or NO BREASTFEEDING JAUNDICE) [1]
Certain ingredients in breast milk slow down conjugation (5-β-pregnane-3α,20-β-diol, nonesterified long-chain fatty acids, glucuronidase)
- THIS IS REFERRED TO AS BREASTMILK JAUNDICE [1]
Evidence supports genetic predisposition [1]
| Feature | Breastfeeding Jaundice | Breastmilk Jaundice |
|---|---|---|
| Timing | First week ("early") | After day 3–5, peaks 2 weeks, may persist to 2–3 months ("late") |
| Mechanism | Inadequate milk intake → dehydration, reduced stool output → increased enterohepatic circulation → more unconjugated bilirubin reabsorbed | Substances in breastmilk (β-glucuronidase, pregnane-3α,20β-diol, fatty acids) inhibit UDPGT and promote deconjugation |
| Type | Unconjugated | Unconjugated |
| Severity | Can be moderate-severe | Usually mild-moderate |
| Management | Improve breastfeeding (lactation support, frequent feeds, correct latch) | Reassurance — continue breastfeeding |
| Key point | Problem is NOT the milk itself but the lack of it | Problem IS the milk (but it's still worth feeding) |
Breastmilk jaundice is a benign condition Jaundice may be prolonged (i.e. beyond 14 days of life) — even up to 2–3 months old All unconjugated (do fractional bilirubin – direct and indirect) Baby healthy otherwise Mothers should be advised to continue breast milk because of the other beneficial effects of breast milk [1]
High Yield — Breastmilk Jaundice
Breastmilk jaundice is a diagnosis of exclusion. Before labelling prolonged jaundice as breastmilk jaundice, you MUST check fractionated bilirubin (must be all unconjugated) and ensure the baby is thriving. Any conjugated component mandates investigation for biliary atresia and other causes. Never tell a mother to stop breastfeeding for breastmilk jaundice.
10. Conjugated Hyperbilirubinemia
Conjugated hyperbilirubinemia does not cause kernicterus, but it can reflect sinister hepatobiliary diseases [1]
This is the pivotal clinical distinction. If the direct (conjugated) bilirubin is elevated, the differential is completely different and potentially surgical.
Conjugated hyperbilirubinemia: when direct bilirubin > 2 mg/dL (35 µmol/L) or > 15% of total serum bilirubin [1]
Associated with:
- Elevated parenchymal/ductal enzymes
- Deranged synthetic functions: e.g. clotting factors, albumin
- Deranged detoxification functions: e.g. hyperammonaemia
- Deranged metabolic function: e.g. hypoglycaemia [1]
Neonatal period:
- Neonatal hepatitis (etiological agents mostly unknown)
- Biliary atresia / choledochal cyst
- Metabolic diseases: e.g. citrin deficiency, galactosemia
- Parenteral nutrition associated cholestasis
- Syndromal disorders
- Neonatal haemochromatosis Beyond neonatal period:
- Viral hepatitis (A–E)
- Drug-induced hepatotoxicity (e.g. paracetamol)
- Wilson's disease
- Haemochromatosis, other metabolic diseases
- Others: choledochal cyst, hereditary hyperbilirubinemia
- Cystic fibrosis [1]
In neonatal period, RULE OUT obstructive jaundice — amenable to surgical treatment:
- Biliary atresia
- Choledochal cyst [1]
Exam Principle
Whenever you see conjugated hyperbilirubinemia in a neonate, the #1 diagnosis to exclude is biliary atresia — because early surgery (Kasai before 12 weeks) dramatically improves outcomes. This is why checking fractionated bilirubin in any jaundiced neonate beyond 2 weeks is mandatory.
11. Biliary Atresia — Detailed Coverage
This is the surgical highlight of the lecture. Biliary atresia is the most common indication for paediatric liver transplantation. [1][4]
Progressive obliterative cholangiopathy due to ductal obstruction [1]
What happens: The extrahepatic (and sometimes intrahepatic) bile ducts undergo progressive inflammatory destruction and fibrosis, leading to complete obstruction of bile flow. The exact aetiology is unknown, but theories include perinatal viral infection triggering an autoimmune-mediated ductal injury, genetic susceptibility, and abnormal morphogenesis.
If untreated → bile accumulates → hepatocyte damage → progressive fibrosis → cirrhosis → portal hypertension → liver failure → death before age 2 without intervention. [4]
Present during or beyond neonatal period with:
- Prolonged jaundice
- Clay-colour stool
- Tea-colour urine
- Poor growth
- Enlarged (or shrunken) liver and spleen [1]
Why clay-coloured stool? No bilirubin reaches the gut (complete biliary obstruction) → no stercobilin → pale/clay/acholic stool. This is one of the most important clinical signs and should trigger urgent investigation.
Why tea-coloured urine? Conjugated bilirubin is water-soluble → spills into urine → dark urine.
Why poor growth? Bile is essential for fat absorption (bile salts emulsify dietary fats for lipase action). Without bile → fat malabsorption → calorie deficiency + fat-soluble vitamin deficiency (A, D, E, K).
Lab: Conjugated hyperbilirubinemia [1]
Additional findings: ↑GGT (characteristically high in biliary atresia — higher than in neonatal hepatitis), ↑ALP, ↑ALT/AST (but often not dramatically elevated), deranged coagulation (from vitamin K malabsorption).
| Investigation | Findings | Purpose |
|---|---|---|
| LFT | ↑Conjugated bilirubin, ↑↑GGT, ↑ALP | Confirm obstructive pattern |
| Fasting US abdomen | Contracted/absent gallbladder, triangular cord sign; bile duct may not be visualised | Non-invasive first-line |
| Cholescintigraphy (EHIDA scan) | No excretion of radiotracer into bowel (after phenobarbital priming) | Differentiates BA vs neonatal hepatitis |
| Liver biopsy | Features of extrahepatic biliary obstruction (bile duct proliferation, bile plugs, portal tract fibrosis) | Gold standard for diagnosis |
| Intraoperative cholangiogram | Failure to outline normal biliary tree | Confirmatory at surgery |
Portoenterostomy before 12 weeks → Best result Beyond 12 weeks → Poor result [1]
The Kasai operation (portoenterostomy) involves:
- Excising the fibrotic extrahepatic biliary remnant
- Exposing the cut surface of the porta hepatis (where tiny residual bile ductules may exist)
- Anastomosing a Roux-en-Y loop of jejunum directly to this cut surface
Why timing matters: Before 12 weeks, there are still microscopic bile ductules at the porta hepatis that can drain bile into the jejunal loop. After 12 weeks, progressive fibrosis obliterates even these tiny channels, making successful drainage unlikely. If diagnosed after 6 weeks in some centres, direct liver transplant is considered. [4]
Outcomes of Kasai:
- ~60% clear jaundice if done before 12 weeks
- Even with successful Kasai, most patients still develop progressive cholangitis and cirrhosis over years
- Kasai is therefore often considered a bridge to transplant, buying time for the child to grow larger (making transplant technically easier)
Portoenterostomy → Jaundice reduced?
- Yes → Jaundice cleared → Watch: Jaundice may recur → Liver transplant if needed
- No → Jaundice persistent → Liver failure → Liver transplant [1]
Indications for liver transplant referral:
- Progressive liver failure
- Growth retardation
- Recurrent cholangitis
- Portal hypertension [1]
BA remains the most common indication for paediatric liver transplant Results of LT for BA patients comparable to non-BA patients (~90% 5-to-10-year survival) Timely referral can reduce morbidity and mortality [1]
HKU experience (1993–2013): 113 recipients, LDLT:DDLT = 83:30, overall 10-year survival ~90%. BA was the most common indication (76 of 113). BA patients had higher pre-LT PELD/MELD scores (25.8 vs 8.2) but comparable post-LT outcomes. [1]
Though less extensively covered in the lecture slides, choledochal cyst is mentioned as the other surgically amenable cause of neonatal conjugated hyperbilirubinemia.
- Definition: Congenital cystic dilatation of the extrahepatic biliary system
- Presentation: Prolonged NNJ, or in older children → RUQ pain, palpable mass, cholangitis
- Investigation: US, MRCP
- Treatment: Surgical excision + Roux-en-Y hepaticojejunostomy
- Complication: Cholangitis, cholangiocarcinoma (2% risk — hence excision rather than drainage)
A newborn with clinical jaundice: 1. History and physical exam → Compatible with "physiologic" jaundice? Any other identifiable factors? Any signs of neurotoxicity? 2. Laboratory test: total serum bilirubin 3. Decide on treatment 4. Counsel parents on treatment and care of baby [1]
14. Exam Intelligence
Based on past papers and lecture emphasis:
-
MCQ: A 5-day-old term baby with unconjugated hyperbilirubinemia — which sign should prompt further investigation? → Answer: Pallor (suggests haemolysis) — from 2023 MCQ Q89. [2]
-
MCQ: A 1-month-old baby with clay-coloured stool, conjugated hyperbilirubinemia, US showing small gallbladder and non-visualised bile duct — most likely diagnosis? → Answer: Biliary atresia — from 2025 MCQ Q49. [3]
-
SAQ: Explain the physiology of neonatal jaundice → Three mechanisms: high Hb load + short RBC lifespan, immature liver (low ligandin + low UDPGT), increased enterohepatic circulation.
-
SAQ: Differentiate breastfeeding jaundice from breastmilk jaundice → See table in Section 9.
-
SAQ: What are the clinical features and management of biliary atresia? → Prolonged jaundice + clay stool + tea urine + hepatosplenomegaly; conjugated hyperbilirubinemia; Kasai before 12 weeks; liver transplant if failed Kasai.
-
SAQ: List the risk factors for kernicterus → Very high bilirubin, free bilirubin, haemolysis, sepsis, acidosis, hypoglycaemia, prematurity.
-
MCQ: A neonate with jaundice — which type of bilirubin does NOT cause kernicterus? → Answer: Conjugated bilirubin (water-soluble, cannot cross BBB).
| Trap | Correct Answer |
|---|---|
| Jaundice at 6 hours = physiological? | No — always pathological |
| Breastmilk jaundice → stop breastfeeding? | No — continue breastfeeding, reassure |
| Conjugated hyperbilirubinemia causes kernicterus? | No — only unconjugated bilirubin crosses BBB |
| Liver palpable 1 cm below costal margin in neonate = pathological? | No — normal in neonates (liver edge normally palpable up to 2 cm below costal margin) |
| Dark urine in unconjugated jaundice? | No — unconjugated bilirubin is albumin-bound, not filtered by kidneys. Dark urine → think conjugated hyperbilirubinemia |
| Kasai procedure is curative? | No — palliative/bridging; most still need liver transplant eventually |
| Comparison | Key Discriminator |
|---|---|
| Physiological vs pathological NNJ | Timing (day 2–3 onset vs < 24h), duration ( < 14 days vs prolonged), severity, presence of conjugated fraction |
| Biliary atresia vs neonatal hepatitis | BA: ↑↑GGT, contracted/absent GB on US, acholic stool; NH: lower GGT, normal GB, may have hepatosplenomegaly from birth |
| Breastfeeding vs breastmilk jaundice | Timing (early vs late), mechanism (insufficient intake vs milk substance inhibition) |
| Phototherapy vs exchange transfusion | Phototherapy for moderate elevation; exchange transfusion for dangerous levels ( > 380 µmol/L) or signs of neurotoxicity |
Q1. A 3-day-old term baby has visible jaundice. Total serum bilirubin is 180 µmol/L, all unconjugated. What is the most likely diagnosis and why? → Physiological jaundice. Onset day 2–3, unconjugated, level commonly > 170 µmol/L, baby otherwise well. Due to high Hb load, immature hepatic conjugation, and increased enterohepatic circulation.
Q2. A baby develops jaundice at 12 hours of age. What should you think of first? → Haemolytic disease (pathological). Check blood group of mother and baby, direct Coombs test, G6PD assay, CBC with reticulocytes, blood smear.
Q3. Name the clinical triad of chronic kernicterus. → Dystonic cerebral palsy, sensorineural hearing loss, upward gaze palsy.
Q4. A 4-week-old breastfed baby remains jaundiced. Fractionated bilirubin shows direct bilirubin 50 µmol/L. What is the most important diagnosis to exclude and why? → Biliary atresia. Because early Kasai portoenterostomy (before 12 weeks) dramatically improves outcomes. Must do urgent US abdomen and refer to paediatric surgery.
Q5. Explain the mechanism of phototherapy. → Blue light (460 nm) causes photo-isomerisation of unconjugated bilirubin to hydrophilic forms (lumirubin, configurational isomers) that can be excreted in bile and urine without requiring hepatic conjugation.
High Yield Summary
Neonatal jaundice is extremely common ( > 50% term, > 80% preterm) and usually physiological (onset day 2–3, peaks day 4–5, resolves by day 7–14, all unconjugated). Three mechanisms: high Hb load + short RBC lifespan, immature liver conjugation (low ligandin + low UDPGT), and increased enterohepatic circulation.
Jaundice < 24 hours = ALWAYS pathological (think haemolysis: ABO/Rh, G6PD). Unconjugated bilirubin crosses the BBB → kernicterus (dystonic CP, SNHL, upward gaze palsy). Risk factors: very high bilirubin, haemolysis, sepsis, acidosis, hypoglycaemia, prematurity.
Treatment: Phototherapy (460 nm, photo-isomerisation) for moderate; exchange transfusion for > 380 µmol/L or neurotoxicity; IVIg for immune haemolysis.
Breastfeeding jaundice ≠ breastmilk jaundice: the former is from insufficient intake (early), the latter from milk substances inhibiting conjugation (late, prolonged, benign — continue breastfeeding).
Conjugated hyperbilirubinemia (direct > 35 µmol/L or > 15% TSB) does NOT cause kernicterus but reflects sinister hepatobiliary disease. In neonates, MUST exclude biliary atresia (clay stool, tea urine, hepatosplenomegaly) and choledochal cyst. Biliary atresia is treated with Kasai portoenterostomy before 12 weeks (best results); it is the most common indication for paediatric liver transplant (~90% 5–10-year survival).
Active Recall - A Jaundiced Child
[1] Lecture slides: GC 146. A jaundiced child.pdf (slides 1–50) [2] Past papers: 2023 Fourth Summative MCQ.pdf (Question 89) [3] Past papers: 2025 Fourth Summative MCQ.pdf (Question 49) [4] Senior notes: Adrian Lui Pediatrics Notes.pdf (pp. 46–48, 264–265) [5] Senior notes: Block A - Introduction to GI_Hepatology investigations (LFT, Endoscopy).pdf (p. 9) [6] Senior notes: MBBS Final MB (Pediatrics) (Felix PY Lai).pdf (pp. 313–314) [7] Senior notes: MBBS Final MB (Surgery) (Felix PY Lai).pdf (p. 433) [8] Senior notes: Ryan Ho Diagnostic Radiology.pdf (p. 64) [9] Senior notes: Maksim Surgery Notes.pdf (pp. 121, 139)
A Critically Ill Child Childhood Medical Emergencies
Childhood medical emergencies are acute, life-threatening clinical situations in pediatric patients requiring immediate recognition and intervention to prevent cardiopulmonary arrest, organ failure, or death.
Heart Failure And Cyanosis In Children Acyanotic And Cyanotic Congenital Heart Disease - Part 1
Congenital heart diseases are classified as acyanotic lesions (e.g., VSD, ASD, PDA) with left-to-right shunts causing heart failure, and cyanotic lesions (e.g., Tetralogy of Fallot, TGA) with right-to-left shunts producing systemic desaturation and cyanosis.